← FDA Drug Approvals (Drugs@FDA)

SUGAMMADEX

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA PHARMACEUTICALS USA INC · Approved 2025-06-27

Drug application

FDA Application #

ANDA218727

Application type

Abbreviated New Drug Application (Generic)

Brand name

SUGAMMADEX

Generic name

Sugammadex

Active ingredients

SUGAMMADEX

Dosage form

INJECTION

Route

SOLUTION

Marketing status

None (Tentative Approval)

Sponsor

HIKMA PHARMACEUTICALS USA INC

First approval

2025-06-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown